138 related articles for article (PubMed ID: 10529627)
1. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
[TBL] [Abstract][Full Text] [Related]
2. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
3. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
[TBL] [Abstract][Full Text] [Related]
4. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
5. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
6. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
7. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
[TBL] [Abstract][Full Text] [Related]
8. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
Arai T; Yamashita S; Yamane M; Manabe N; Matsuzaki T; Kiriyama K; Kanayama Y; Himeno S; Matsuzawa Y
Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
[TBL] [Abstract][Full Text] [Related]
9. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
[TBL] [Abstract][Full Text] [Related]
11. Hypobetalipoproteinemia associated with apo B-48.4, a truncated protein only 14 amino acids longer than apo B-48.
Ruotolo G; Zanelli T; Tettamanti C; Ragogna F; Parlavecchia M; Viganò F; Catapano AL
Atherosclerosis; 1998 Mar; 137(1):125-31. PubMed ID: 9568744
[TBL] [Abstract][Full Text] [Related]
12. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Xie W; Xie Y; Lin Z; Xu X; Zhang Y
Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
[TBL] [Abstract][Full Text] [Related]
13. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
14. Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population.
Yang AH; Ng YY; Tarng DC; Chen JY; Shiao MS; Kao JT
Nephron; 1998; 78(3):266-70. PubMed ID: 9546684
[TBL] [Abstract][Full Text] [Related]
15. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
Han HL; Lin S; Sun LS; Zhang P; Zhai DP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism and lipoprotein compositions in patients with Behçet's disease.
Tursen U; Eskandari G; Kaya TI; Tamer L; Ikizoglu G; Atik U
Int J Dermatol; 2004 Dec; 43(12):900-3. PubMed ID: 15569012
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD.
Yokota H; Hashimoto Y; Okubo S; Yumoto M; Mashige F; Kawamura M; Kotani K; Usuki Y; Shimada S; Kitamura K; Nakahara K
Atherosclerosis; 2002 Jun; 162(2):399-407. PubMed ID: 11996960
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.
Miyata T; Sugiyama S; Nangaku M; Suzuki D; Uragami K; Inagi R; Sakai H; Kurokawa K
J Am Soc Nephrol; 1999 Jul; 10(7):1590-5. PubMed ID: 10405216
[TBL] [Abstract][Full Text] [Related]
20. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
